Contact Information: Media Inquiries Amy Groden-Morrison TIBCO Software Inc. 617-702-1710 amorriso@tibco.com http://spotfire.tibco.com Toni Iafrate Davies Murphy Group 781-418-2406 tiafrate@daviesmurphy.com http://daviesmurphy.com
TIBCO Spotfire and Integromics Unveil New Genomics Data Analysis Solution to Speed Drug Research, Development
Integromics Biomarker Discovery 2.0 for TIBCO Spotfire(R) Sets Industry Standard for Advancing Life Sciences Research, Discovery, and Development
| Source: TIBCO Software Inc.
SOMERVILLE, MA--(Marketwire - October 19, 2009) - TIBCO Software Inc. (NASDAQ : TIBX ), together
with INTEGROMICS, a provider of state-of-the-art software solutions for
data management and data analysis in genomics, proteomics and drug
discovery, today announced
Integromics Biomarker Discovery 2.0 for TIBCO Spotfire®, a new
solution that sets the standard for advanced methods of data access,
normalization, pattern detection, treatment comparison, and functional
analysis for scientists analyzing genomic expression data. This powerful
platform plays a pivotal role in leveraging the substantial investment in
gene expression technologies that the pharmaceutical and biotechnology
industries have made in the last decade. Gaining new insights into disease
biology, mechanism of action, and drug safety will be a key differentiator
in early drug discovery.
The scientific and workflow knowledge of INTEGROMICS -- combined with the
adaptability and ease of use of the TIBCO Spotfire®
Enterprise Analytics Platform -- provides pharmaceutical,
biotechnology, and academic research groups a powerful genomic data
analysis environment that quickly finds and categorizes complex patterns.
With interactive analysis and high-impact visualization capabilities,
Integromics Biomarker Discovery 2.0 for TIBCO Spotfire® rapidly reveals
insights and unexpected relationships in genomics data. This allows
researchers and scientists to examine the expression and annotation
dimensions of their data and perform a variety of numerical analyses -- all
in a single application. Pharmaceutical companies can also use TIBCO
Spotfire® as a flexible analytics platform to combine and analyze new
types of data to more quickly pursue hypotheses and research strategies.
"Integromics Biomarker Discovery is a streamlined tool for new biomarker
discovery in clinical trials. The product, built on the powerful Spotfire
platform, affords the user considerable flexibility in finding creative
answers to challenging scientific questions," said Shoba Sharma, principal,
VizMetrix. "The solution implementation has added important analytic and
workflow extensions to Spotfire's core visualization capabilities.
Furthermore, the Integromics technical team is very forthcoming in
providing support from both technical and bioinformatics perspectives to
enable users to devise innovative solutions for research and discovery."
"Having developed microarray analytics for over five years and benefitted
from a successful partnership with Spotfire for several years now, we are
confident that this combined solution will provide researchers with a
powerful environment to accelerate discovery and provide accurate,
up-to-date analytics from a single reliable source," said Imad Yassin,
Global commercial Director, INTEGROMICS. "With this set of tools, life
science researchers can ask and answer new questions and create an advanced
problem solving environment."
"Genomics research typically involves measuring the activity of thousands
of genes in many different treatments or conditions, and combining that
information with other data to uncover new insight into the biology of
disease and treatment," said Mark Lorion, vice president of Marketing,
TIBCO Spotfire. "This solution helps researchers and scientists address
one of the industry's long standing challenges of creating knowledge from
mass data by easily integrating multiple data sources and transforming data
into an interactive decision-making asset."
Availability
Integromics Biomarker Discovery 2.0 for TIBCO Spotfire® is available now.
For more information visit: http://goto.spotfire.com/g/?YYM5SS96SH.
About INTEGROMICS
Integromics develops state-of-the-art IT solutions for Life Sciences
(Genomics and Proteomics) in two strategic areas: data
management/integration and intelligent data analysis. Over the years, the
company has developed a network of collaborations and partnerships with
leading industry and academic organizations to provide complete
technological solutions that enable scientists to make new discoveries from
their research data. Integromics operates globally in Asia Pacific, Europe
and USA. For more information: www.integromics.com.
About TIBCO
TIBCO Software Inc. (NASDAQ : TIBX ) is a leading provider of enterprise
analytics software for next generation business intelligence. TIBCO
Spotfire products offer a visual and interactive experience that helps
professionals quickly discover new and actionable insights in information.
Distinguished by its speed to insight and adaptability to specific business
challenges, Spotfire rapidly reveals unseen threats and new opportunities,
creating significant economic value. Spotfire customers include industry
leaders among the Global 2000 that have deployed Spotfire analytics to gain
an information advantage over their competitors. For more information,
visit http://spotfire.tibco.com.
TIBCO, TIBCO Software and TIBCO Spotfire are trademarks or registered
trademarks of TIBCO Software Inc. or its subsidiaries in the United States
and/or other countries. Integromics and Integromics Biomarker Discovery are
registered trademarks of Integromics. All other product and company names
and marks mentioned in this document are the property of their respective
owners and are mentioned for identification purposes only.